Abstract
This review describes the application of a natural defense mechanism to develop effective agents for The post-transcriptional control of gene expression. 2-5A is a unique 2,5-phosphodiester bond linked oligoadenylate, (pp)p5A2(p5A)n , that is elaborated in virus-infected interferon-treated cells. The 2-5A System is an RNA degradation pathway that is an important mechanistic component of interferons action against certain viruses. It may also play a role in the anticellular effects of interferon and in general RNA decay. A major player in the 2-5A-system is the latent and constitutive 2-5A-dependent ribonuclease (RNase L) which upon activation by 2-5A, degrades RNA. This RNase L enzyme can be recruited for antisense therapeutics by linking it to an appropriate oligonucleotide targeted to a chosen RNA. Syntheses of 2-5A, its analogues, 2-5A-antisense, and its modifications are detailed herein. Applications of 2-5A-antisense to particular targets such as HIV, PKR, chronic myelogenous leukemia, telomerase, and respiratory syncytical Virus is described.
Keywords: Oligoadenylate-Based Antisense, Ribonucleases, Apoptosis, 2-5A-ANTI-SENSE(2-5A-AS), Syncytial Virus, Condensation, Coupling agents
Current Medicinal Chemistry
Title: Chemistry and Biochemistry of 2, 5-Oligoadenylate-Based Antisense Strategy
Volume: 8 Issue: 10
Author(s): Steven A. Adah, Suzanne F. Bayly, Hagen Cramer, Robert H. Silverman and Paul F. Torrence
Affiliation:
Keywords: Oligoadenylate-Based Antisense, Ribonucleases, Apoptosis, 2-5A-ANTI-SENSE(2-5A-AS), Syncytial Virus, Condensation, Coupling agents
Abstract: This review describes the application of a natural defense mechanism to develop effective agents for The post-transcriptional control of gene expression. 2-5A is a unique 2,5-phosphodiester bond linked oligoadenylate, (pp)p5A2(p5A)n , that is elaborated in virus-infected interferon-treated cells. The 2-5A System is an RNA degradation pathway that is an important mechanistic component of interferons action against certain viruses. It may also play a role in the anticellular effects of interferon and in general RNA decay. A major player in the 2-5A-system is the latent and constitutive 2-5A-dependent ribonuclease (RNase L) which upon activation by 2-5A, degrades RNA. This RNase L enzyme can be recruited for antisense therapeutics by linking it to an appropriate oligonucleotide targeted to a chosen RNA. Syntheses of 2-5A, its analogues, 2-5A-antisense, and its modifications are detailed herein. Applications of 2-5A-antisense to particular targets such as HIV, PKR, chronic myelogenous leukemia, telomerase, and respiratory syncytical Virus is described.
Export Options
About this article
Cite this article as:
Adah A. Steven, Bayly F. Suzanne, Cramer Hagen, Silverman H. Robert and Torrence F. Paul, Chemistry and Biochemistry of 2, 5-Oligoadenylate-Based Antisense Strategy, Current Medicinal Chemistry 2001; 8 (10) . https://dx.doi.org/10.2174/0929867013372445
DOI https://dx.doi.org/10.2174/0929867013372445 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Innate Inflammatory Responses in Stroke: Mechanisms and Potential Therapeutic Targets
Current Medicinal Chemistry Plant Phenylpropanoids as Emerging Anti-Inflammatory Agents
Mini-Reviews in Medicinal Chemistry Roadmap to Cellular Reprogramming – Manipulating Transcriptional Networks with DNA, RNA, Proteins and Small Molecules
Current Molecular Medicine Sepsis Pathophysiology and Anesthetic Consideration
Cardiovascular & Hematological Disorders-Drug Targets Pigment Epithelium-Derived Factor (PEDF) Prevents Advanced Glycation End Products (AGEs)-Elicited Endothelial Nitric Oxide Synthase (eNOS) Reduction Through Its Anti-Oxidative Properties
Protein & Peptide Letters An Overview of the Pharmacological Properties and Potential Applications of Natural Monoterpenes
Mini-Reviews in Medicinal Chemistry Helicobacter Pylori, Zinc and Iron in Oxidative Stress-Induced Injury of Gastric Mucosa
Mini-Reviews in Medicinal Chemistry Host-Pathogen Interactions and the Pathological Consequences of Acute Systemic Candida albicans Infections in Mice
Current Drug Targets Editorial [Hot topic: Hepatocyte Growth Factor and cMET, New Development in Cancer Therapies (Guest Editors: T.A. Martin and W.G. Jiang)]
Anti-Cancer Agents in Medicinal Chemistry Ceramide Kinase and the Ceramide-1-Phosphate/cPLA2α Interaction as a Therapeutic Target
Current Drug Targets Combined Chemotherapy or Biotherapy with Jasmonates: Targeting Energy Metabolism for Cancer Treatment
Current Pharmaceutical Biotechnology Cellular Mechanisms of Brain Injury and Cell Death
Current Pharmaceutical Design An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors
Current Cancer Drug Targets Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents
Current Cancer Drug Targets COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases
Current Rheumatology Reviews Viral Proteases as Targets for Drug Design
Current Pharmaceutical Design Molecular Mechanisms of the Antiatherogenic Action of Adiponectin
Vascular Disease Prevention (Discontinued) Application of Novel Nanotechnology Strategies in Plant Biotransformation: A Contemporary Overview
Recent Patents on Biotechnology Eph/ephrin Signaling as a Potential Therapeutic Target After Central Nervous System Injury
Current Pharmaceutical Design Prescription Opioid Abuse and its Potential Role in Gross Dental Decay
Current Drug Safety